A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified December 2012 by Severance Hospital
Sponsor:
Information provided by (Responsible Party):
Byeong Woo Park, Severance Hospital
ClinicalTrials.gov Identifier:
NCT01752686
First received: September 26, 2012
Last updated: December 21, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)